Review



macrophage attachment medium  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    PromoCell macrophage attachment medium
    APS increased the differentiation of <t>macrophages</t> down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.
    Macrophage Attachment Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/macrophage attachment medium/product/PromoCell
    Average 94 stars, based on 6 article reviews
    macrophage attachment medium - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "Mechanistic Insights and Real-World Evidence of Autologous Protein Solution (APS) in Clinical Use † "

    Article Title: Mechanistic Insights and Real-World Evidence of Autologous Protein Solution (APS) in Clinical Use †

    Journal: International Journal of Molecular Sciences

    doi: 10.3390/ijms26157577

    APS increased the differentiation of macrophages down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.
    Figure Legend Snippet: APS increased the differentiation of macrophages down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.

    Techniques Used: Control



    Similar Products

    macrophage attachment medium  (PromoCell)
    94
    PromoCell macrophage attachment medium
    APS increased the differentiation of <t>macrophages</t> down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.
    Macrophage Attachment Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/macrophage attachment medium/product/PromoCell
    Average 94 stars, based on 1 article reviews
    macrophage attachment medium - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    c 28051 macrophage detachment solution dxf promocell  (PromoCell)
    95
    PromoCell c 28051 macrophage detachment solution dxf promocell
    APS increased the differentiation of <t>macrophages</t> down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.
    C 28051 Macrophage Detachment Solution Dxf Promocell, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c 28051 macrophage detachment solution dxf promocell/product/PromoCell
    Average 95 stars, based on 1 article reviews
    c 28051 macrophage detachment solution dxf promocell - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    macrophage differentiation  (PromoCell)
    95
    PromoCell macrophage differentiation
    Figure 5. CC-LR mice show a fall in (a) M1-type antitumoral <t>macrophages</t> and a small rise in (b) protumoral M2-type macrophages. With myo-inositol, there is a recovery of the fall in M1 macrophages with no significant change in M2 macrophages. For M1 macrophages, p 5 0.002 for LR vs CC-LR on control diet, p 5 0.03 for LR vs CC-LR on myo-inositol, p 5 0.008 for CC-LR on control vs myo-inositol diet; for M2 macrophages, p 5 0.019 for CC-LR vs LR on control diet and p 5 0.029 for CC-LR vs LR on myo-inositol. (c) myo-inositol at 5 mM does not affect healthy PBMC differentiation into an M1-like phenotype (CD68hiCD861CD163-) but increases M2-like differentiation (CD68hiCD861CD1631). In M2 differentiation media, PBMCs that do not become CD1631 show an M2b-like phenotype. The percentage of these cells decrease with myo-inositol. (d–f) myo-inositol decreases IL-6 secretion in M1-like (d, p 5 0.010), M2-like (e, p 5 0.001), and M2b-like (f, p 5 0.022) cells. * indicates p < 0.05 by t test. n 5 5 mice for each genotype and diet used.
    Macrophage Differentiation, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/macrophage differentiation/product/PromoCell
    Average 95 stars, based on 1 article reviews
    macrophage differentiation - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    APS increased the differentiation of macrophages down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.

    Journal: International Journal of Molecular Sciences

    Article Title: Mechanistic Insights and Real-World Evidence of Autologous Protein Solution (APS) in Clinical Use †

    doi: 10.3390/ijms26157577

    Figure Lengend Snippet: APS increased the differentiation of macrophages down the M2 lineage ( A ) (CD68+ and CD163+) and inhibited the differentiation of macrophages down the M1 pro-inflammatory lineage ( B ) (CD80+). * indicates p = 0.01; significant from control media after two-way ANOVA.

    Article Snippet: The peripheral monocytes were cultured with macrophage attachment medium (Promocell, PN: C-28052, Heidelberg, Germany) and then in macrophage attachment medium (Promocell, PN: C-28057, Heidelberg, Germany) for 6 days.

    Techniques: Control

    Figure 5. CC-LR mice show a fall in (a) M1-type antitumoral macrophages and a small rise in (b) protumoral M2-type macrophages. With myo-inositol, there is a recovery of the fall in M1 macrophages with no significant change in M2 macrophages. For M1 macrophages, p 5 0.002 for LR vs CC-LR on control diet, p 5 0.03 for LR vs CC-LR on myo-inositol, p 5 0.008 for CC-LR on control vs myo-inositol diet; for M2 macrophages, p 5 0.019 for CC-LR vs LR on control diet and p 5 0.029 for CC-LR vs LR on myo-inositol. (c) myo-inositol at 5 mM does not affect healthy PBMC differentiation into an M1-like phenotype (CD68hiCD861CD163-) but increases M2-like differentiation (CD68hiCD861CD1631). In M2 differentiation media, PBMCs that do not become CD1631 show an M2b-like phenotype. The percentage of these cells decrease with myo-inositol. (d–f) myo-inositol decreases IL-6 secretion in M1-like (d, p 5 0.010), M2-like (e, p 5 0.001), and M2b-like (f, p 5 0.022) cells. * indicates p < 0.05 by t test. n 5 5 mice for each genotype and diet used.

    Journal: International journal of cancer

    Article Title: Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol.

    doi: 10.1002/ijc.31152

    Figure Lengend Snippet: Figure 5. CC-LR mice show a fall in (a) M1-type antitumoral macrophages and a small rise in (b) protumoral M2-type macrophages. With myo-inositol, there is a recovery of the fall in M1 macrophages with no significant change in M2 macrophages. For M1 macrophages, p 5 0.002 for LR vs CC-LR on control diet, p 5 0.03 for LR vs CC-LR on myo-inositol, p 5 0.008 for CC-LR on control vs myo-inositol diet; for M2 macrophages, p 5 0.019 for CC-LR vs LR on control diet and p 5 0.029 for CC-LR vs LR on myo-inositol. (c) myo-inositol at 5 mM does not affect healthy PBMC differentiation into an M1-like phenotype (CD68hiCD861CD163-) but increases M2-like differentiation (CD68hiCD861CD1631). In M2 differentiation media, PBMCs that do not become CD1631 show an M2b-like phenotype. The percentage of these cells decrease with myo-inositol. (d–f) myo-inositol decreases IL-6 secretion in M1-like (d, p 5 0.010), M2-like (e, p 5 0.001), and M2b-like (f, p 5 0.022) cells. * indicates p < 0.05 by t test. n 5 5 mice for each genotype and diet used.

    Article Snippet: For macrophage differentiation, PBMCs were incubated in monocyte attachment medium (PromoCell, Heidelberg, Germany) at 378C.

    Techniques: Control